MTT5, a toll-like receptor 7 (TLR7) agonist, can be conjugated with Deruxtecan to exert antitumor activity in HER2-positive solid tumors through tumor cell killing and immune activation.
Molecular Weight:
453.49
Formula:
C22H27N7O4
Target:
TLR
* VAT and and shipping costs not included. Errors and price changes excepted
